12
Nov
SAHPRA’s Response to Medical Brief article
SAHPRA wishes to correct the inaccuracies in the Medical Brief article titled “H...
-
-
20OctSAHPRA REFUTES CLAIMS BY THE BLACK FARMERS ASSOCIATION
SAHPRA refutes claims made by the Black Farmers Association of South Africa (BFA...
-
12Oct
SAHPRA’S STANCE ON THE ANHP JUDGEMENT
On 01 October 2020, the Pretoria High Court delivered its judgment in the matter...
-
30MarCOVID-19 – THE APPROPRIATE PLACE FOR RAPID TEST KITS
In line with the recommendation of the South African National Institute for Comm...
-
25MarTHE USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH COVID-19
The South African Health Products Regulatory Authority (SAHPRA) has become aware...
-
13DecSAHPRA and Law Enforcement seize illegal products
The South African Health Products Regulatory Authority (SAHPRA) worked together ...
-
12DecMetformin – Under Investigation regarding the possible contamination by NDMA
The South African Health Products Regulatory Authority (SAHPRA) has become aware...
-
04Nov -
29OctSAHPRA FINAL MEDIA RELEASE UPDATE ON RANITIDINE CONTAINING MEDICINES
The South African Health Products Regulatory Authority (SAHPRA) would like to up...
-
25OctCANNABIS AND RELATED SUBSTANCES
Between 60 and 100 chemicals called cannabinoids and some 300 non-cannabinoid ch...
-
19Oct -
14OctCANNABIS LICENSING
The South African Health Products Regulatory Authority (SAHPRA) notes with conce...
-
12Oct
RANITIDINE CONTAINING MEDICINES UPDATE
The South African Health Products Regulatory Authority (SAHPRA) has learned abou...
-
08OctMEET THE SAHPRA CEO
SAHPRA is pleased to announce the appointment of a new Chief Executive Officer, ...
-
07OctMr Khamusi Mutoti appointed Chairperson of African Blood Regulator’ Forum (ABRF)
Mr Khamusi Mutoti, Biological Medicine Manager at SAHPRA, was elected the Chairp...